Related Experiment Videos
Stealth liposomes and tumor targeting: one step further in the quest for the magic bullet
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Phase I study of doxil-cisplatin combination chemotherapy in patients with advanced malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research·2001
Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy.
Cancer investigation·2001
Reduction of the systemic toxicity of cisplatin by intra-arterial hepatic route administration for liver malignancies.
International journal of cancer·1995
Liposomal anthracyclines.
Hematology/oncology clinics of North America·1994
In vitro cytotoxicity of liposome-encapsulated doxorubicin: dependence on liposome composition and drug release.
Biochimica et biophysica acta·1992
Developing Effective, Evidence-Based Training for Cancer Team Science Leadership for National Impact.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
The Next Frontier in Quantitative Co-Clinical Imaging to Advance Functional Precision Oncology.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Safety and Efficacy of Ceralasertib plus Olaparib for Advanced/Metastatic Triple-Negative Breast Cancer in Three Molecular Strata: The Phase II VIOLETTE Study.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Evaluation of MET Detection Methods and Cutoffs in EGFR-Mutated Non-small Cell Lung Cancer Following Disease Progression on Osimertinib in the phase II SAVANNAH study.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Beyond Major Pathologic Response in Lung Cancer: Biomarkers Predict Outcomes.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Amivantamab plus pembrolizumab in previously untreated recurrent/metastatic head and neck squamous cell cancer: Results from the phase 1b/2 OrigAMI-4 study.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026